INS and obesity due to melanocortin 4 receptor deficiency: SCFAs also contribute to improved metabolic health and reduced obesity risk by enhancing insulin sensitivity (Pham et al., 2024) and promoting the secretion of satiety hormones (Chambers et al., 2018).